JHOP (@jhoponline) 's Twitter Profile
JHOP

@jhoponline

Journal of Hematology Oncology Pharmacy, the peer-reviewed forum for oncology pharmacy practice. A @TheLynxGroup journal and the official publication of @HOPArx

ID: 1382684987401601026

linkhttp://jhoponline.com/ calendar_today15-04-2021 13:19:40

234 Tweet

261 Takipçi

93 Takip Edilen

JHOP (@jhoponline) 's Twitter Profile Photo
JHOP
@jhoponline

3 years ago

A clinical trial investigated effects of treatment with the androgen receptor inhibitor darolutamide, in combination with androgen-deprivation therapy (ADT) and docetaxel, in patients with metastatic hormone-sensitive prostate cancer (HSPC). bit.ly/3Portcu

A clinical trial investigated effects of treatment with the androgen receptor inhibitor darolutamide, in combination with androgen-deprivation therapy (ADT) and docetaxel, in patients with metastatic hormone-sensitive prostate cancer (HSPC). bit.ly/3Portcu